Here's your Forbes Daily Briefing for Thursday, April 10th.

Today on Forbes, Trump's tariffs, coming to your medicine cabinet soon.

On average, Americans pay about twice what other countries do for prescription drugs.

Thanks to President Trump's aggressive tariffs and the global trade war they are inciting,

they might soon pay even more.

Last week, Trump made good on a core campaign promise to enact sweeping tariffs,

slapping a baseline of 10% tax on imports from every country,

with China, India, and EU countries singled out for harsher rates.

But as of Wednesday afternoon, Trump suddenly announced a pause on most reciprocal tariffs,

except China, which he hit with a 125% levy, up from 104% a day earlier,

after China enacted its own retaliatory tariff in an escalating trade war.

Although pharmaceuticals are currently exempt, it's widely expected that won't last.

In his remarks announcing tariffs last week, Trump said, quote,

the pharmaceutical companies are going to come roaring back, because if they don't, they've got a big tax to pay.

Suggesting, it's only a question of when and how hard pharmaceutical tariffs will hit. When they do, one of the

biggest losers would likely be generic drug manufacturers, and, since they account for about

90% of all prescriptions in the United States, a huge segment of Americans who rely on them.

About 47% of all generics prescribed in the U.S. are made in India, which was facing a 26%

tariff before Trump's pause announcement. Some, like common heart medications, cost less than

a dollar a pill, a price that, if tariffed, might cause

their manufacturers to reconsider the value proposition of making them.

Rajiv Leventhal, a healthcare analyst at e-marketer, said, quote, most of them are selling

...